Compare GRWG & CPIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | GRWG | CPIX |
|---|---|---|
| Founded | 2008 | 1999 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | RETAIL: Building Materials | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 89.6M | 98.3M |
| IPO Year | 2015 | 2007 |
| Metric | GRWG | CPIX |
|---|---|---|
| Price | $1.27 | $6.08 |
| Analyst Decision | Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $2.50 | N/A |
| AVG Volume (30 Days) | ★ 283.3K | 174.8K |
| Earning Date | 11-10-2026 | 11-10-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 51.22 | ★ 58.70 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $193,365,479.00 | $42,010,949.00 |
| Revenue This Year | $2.33 | N/A |
| Revenue Next Year | $3.82 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 142.51 | 16.75 |
| 52 Week Low | $1.01 | $1.85 |
| 52 Week High | $2.40 | $9.28 |
| Indicator | GRWG | CPIX |
|---|---|---|
| Relative Strength Index (RSI) | 31.19 | 53.65 |
| Support Level | $1.04 | $5.76 |
| Resistance Level | $1.58 | $8.20 |
| Average True Range (ATR) | 0.08 | 0.85 |
| MACD | -0.01 | 0.11 |
| Stochastic Oscillator | 30.43 | 49.04 |
GrowGeneration Corp owns and operates specialty retail stores focused on hydroponic and organic gardening. The company markets and distributes nutrients, growing media, indoor and greenhouse lighting, ventilation systems, and related accessories. It operates through two reportable segments: Cultivation and Gardening, which includes its hydroponic and organic gardening business, and Storage Solutions, which includes its benching, racking, and storage solutions operations. The company generates revenue mainly from the sale of proprietary and non-proprietary products through retail stores, e-commerce platforms, wholesale distribution, and commercial sales, along with the sale and installation of commercial fixtures.
Cumberland Pharmaceuticals Inc is a specialty pharmaceutical company focused on the acquisition, development, and commercialization of branded prescription pharmaceutical products. The Company has one operating segment, which is specialty pharmaceutical products. The company's target markets are hospital acute care, gastroenterology, rheumatology, and oncology. The firm promotes its approved products through its hospital, field, and oncology sales divisions in the United States and establishes a network of international partners to register and provide medicines to patients in their countries. Its brands include Acetadote, Caldolor, Kristalose, Sancuso, Vaprisol, and Vibativ. Geographically, the company generates revenue from China, South Korea, Russia, Mexico, Australia, and Saudi Arabia.